MI-EATON
28.2.2023 19:50:44 CET | Business Wire | Press release
Intelligent power management company Eaton today announced its Vehicle Group's cylinder deactivation (CDA) and late intake valve closing (LIVC) technologies have been proven to simultaneously reduce nitrogen oxides (NOx) and carbon dioxide (CO2). The technologies were shown to be effective for meeting future global emissions requirements for diesel-engine powered commercial vehicles, according to a recent series of tests conducted by FEV, a recognized leader in design and development of advanced gasoline, diesel and hybrid powertrains and vehicle systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230228006254/en/
Eaton’s cylinder deactivation (CDA) and late intake valve closing (LIVC) have been proven to simultaneously reduce nitrogen oxides (NOx) and carbon dioxide (CO2). (Photo: Business Wire)
Testing measured fuel consumption and exhaust temperature, from which engine-out NOx and CO2 were determined. Results indicated the CDA created up to a 38% reduction of NOx compared with 13% for LIVC thanks to exhaust gasses temperature increase, which enables optimal emissions aftertreatment performance. The results were delivered while simultaneously reducing CO2 emissions.
During the evaluation, the standard valvetrain on an 11-liter diesel engine was replaced with Eaton’s variable valve actuation system able to deliver either CDA or LIVC functions. The engine was put on a dynamometer and tested in standard engine and in varying CDA and LIVC engine modes to determine optimal thermal management effects and fuel savings.
“Emissions regulations are driving the adoption of variable valve actuation solutions by our global commercial vehicle customers,” said Fabiano Contarin, product director, Commercial Vehicle Valve Actuation, Eaton’s Vehicle Group. “Our portfolio of technologies is helping manufacturers meet the upcoming regulations in a number of ways based on customer preference.”
Eaton’s CDA also resulted in a 3% decrease in fuel consumption in a low-load cycle, while LIVC lowered fuel consumption by 0.5%. Additionally, CDA in three-cylinder mode raised exhaust temperatures up to 175 degrees Celsius which helped increase the efficiency of a selective catalytic reduction (SCR) system.
The study results confirm earlier findings of tests conducted in the U.S. by Eaton and the Southwest Research Institute (SwRI), one of the oldest and largest independent, nonprofit applied research and development organizations. The findings of the U.S.-based tests found using CDA and a close-coupled selective catalytic reduction (SCR) catalyst reduced CO2 emissions by 4% in a low load cycle with NOx emission of 0.02 g/hp-hr.
“If a low-load cycle is a customer’s focus, then CDA is the ideal technology,” Contarin said. “LIVC, instead, provides lower benefits but in a wider range of the engine map, especially when combined with a higher compression ratio.”
Learn more about Eaton’s variable valve actuation solutions.
Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for our stakeholders and all of society.
Founded in 1911, Eaton is marking its 100th anniversary of being listed on the New York Stock Exchange. We reported revenues of $20.8 billion in 2022 and serve customers in more than 170 countries. For more information, visit www.eaton.com. Follow us on Twitter and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006254/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lone Star Funds Completes Acquisition of Alliance Ground International26.3.2026 13:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has completed the acquisition of Alliance Ground International (“AGI”), a leading North American airport services provider. “We are excited to partner with the AGI management team to drive the business forward,” said Donald Quintin, Chief Executive Officer of Lone Star. “The company has a superior service offering and a track record of success across its integrated operations. We see opportunities to continue to invest in the business and its people to continue to grow its capabilities and ensure it remains best-in-class in delivering for the aviation industry.” “Today marks an important next step for AGI as we move forward in partnership with Lone Star,” said Jared Azcuy, Chief Executive Officer of AGI. “Our commitment to safety, reliability, and operational service excellence remains unchanged. This partnership strengthens our ability to deliver for our airline partners and reinforces that the
Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging26.3.2026 13:30:00 CET | Press release
The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4) modulator, met its primary endpoint and also demonstrated a statistically significant relationship between target engagement and clinical improvement in psoriasis and atopic dermatitis RLS-1496 is a first-in-class disease-modifying mechanism targeting pathological senescent cells that drive inflammaging and chronic degenerative diseases of aging A second study for RLS-1496 – a Phase 1b/2a study in actinic keratosis (precancerous skin lesions) – is underway in the United States, with completion expected later this year Rubedo CEO Frederick Beddingfield, III, MD, PhD, FAAD, to moderate panel on senescence and skin at the Dermatology Innovation Forum (DIF) during the American Academy of Dermatology (AAD) annual meeting on Thursday, March 26, at 1:05 pm MT in Denver Oral presentation of data accepted at the Society for Investigative Dermatology (SID) from May 13-16, 2026, in Chicago Rubedo L
GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe26.3.2026 13:30:00 CET | Press release
COMPASS is one of the largest public‑private partnerships under the European Union’s (EU) Innovative Health Initiative (IHI). The consortium aims to advance early detection and prediction of cardiotoxicity in cancer patients and cancer survivors. The initiative will leverage AI, advanced imaging, biomarkers, and integrated care pathways. GE HealthCare (Nasdaq: GEHC) today announced its leading industrial role in the new COMPASS consortium, a five-year initiative focused on improving precision cardio-oncology care and advancing early detection of cardiovascular risks in cancer patients across Europe. COMPASS combines clinical excellence with novel healthcare technology, and with a total budget of €50.5 million and more than sixty partners, it is one of the largest public-private partnerships under the IHI. Cardiovascular diseases are rising sharply among cancer patients and survivors, driven both by the increasing prevalence of pre‑existing cardiovascular conditions at diagnosis and by
M1X Global Announces Public Launch and Oversubscribed $3 Million Angel Round to Scale On-Chain Sovereign Finance26.3.2026 13:13:00 CET | Press release
M1X Global, a sovereign financial infrastructure and technology company, today announced its public launch alongside the close of an oversubscribed $3 million angel round. The funding, spanning strategic investments and grants, will support platform development and accelerate regulated institutional adoption of USDM1, the first USD-denominated, treasury collateralized sovereign debt instrument issued natively by a sovereign on public blockchain infrastructure. The $3 million in funding drew participation from leading figures across global capital markets and digital asset infrastructure, including Balaji Srinivasan, former CTO of Coinbase; Tama Churchouse, CEO of Cumberland Labs; Richard Gorelick, former Head of Market Structure at DRW; and Dan Robichaud, former CIO at Intel. Institutional participation from FJ Labs and grant funding from Stellar Development Foundation reflect strong alignment between private capital and mission-driven partners advancing blockchain-based market develop
500 Global Taps Former IFC CIO As Firm Expands Global Investment Platform26.3.2026 13:00:00 CET | Press release
Atul Mehta brings three decades of global investment leadership to board as 500 Global scales platforms aligning venture capital with national innovation and economic growth agendas. 500 Global today announced the appointment of Atul Mehta to its Board of Directors, marking an important step in the firm’s continued evolution as a global venture platform and institutional asset manager. Mehta brings more than three decades of global investment and institutional leadership experience at a time when 500 Global has observed governments, multilateral institutions, and long-term capital providers rethinking how technology-led growth is financed and scaled. He has held senior roles across private capital and development finance, including at the International Finance Corporation (IFC), where he managed multi-billion-dollar portfolios spanning technology, venture funds, infrastructure, agribusiness, healthcare, education, and financial services across emerging markets. Over his career, he has
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
